The Patent Finder

Hetero Labs Limited

Also on record
Records under this name other than the patents Hetero Labs Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 6 of 6 · Back to Hetero Labs Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,669,305C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors
Lapsed on the fee record
Ended Jun 2, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 2, 2024USPTO record
US 10,370,405C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
Lapsed on the fee record
Ended Aug 6, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 6, 2023USPTO record
US 9,868,758Betulinic proline imidazole derivatives as HIV inhibitors
Lapsed on the fee record
Ended Jan 16, 2022 · USPTO record
Lapsed on the fee recordEnded Jan 16, 2022USPTO record
US 9,637,516Betulinic acid proline derivatives as HIV inhibitors
Lapsed on the fee record
Ended May 2, 2021 · USPTO record
Lapsed on the fee recordEnded May 2, 2021USPTO record
US 9,067,966Lupeol-type triterpene derivatives as antivirals
Lapsed on the fee record
Ended Jun 30, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 30, 2019USPTO record
US 8,802,727Pharmaceutically acceptable salts of betulinic acid derivatives
Lapsed on the fee record
Ended Aug 12, 2018 · USPTO record
Lapsed on the fee recordEnded Aug 12, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited